SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-022233
Filing Date
2021-09-16
Accepted
2021-09-15 21:47:11
Documents
18
Period of Report
2021-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20210914_8k.htm   iXBRL 8-K 35000
2 EXHIBIT 1.1 ex_283864.htm EX-1.1 252431
3 EXHIBIT 5.1 ex_283865.htm EX-5.1 39595
8 thlogo02.jpg GRAPHIC 14824
9 thlogo.jpg GRAPHIC 15373
10 thsig.jpg GRAPHIC 4482
  Complete submission text file 0001437749-21-022233.txt   579103

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20210913.xsd EX-101.SCH 3594
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20210913_def.xml EX-101.DEF 11425
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20210913_lab.xml EX-101.LAB 15311
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20210913_pre.xml EX-101.PRE 11585
11 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20210914_8k_htm.xml XML 2556
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 211256841
SIC: 2836 Biological Products, (No Diagnostic Substances)